2026 Annual Meeting | C46 - Myelin Oligodendrocyte Glycoprotein Antibody Disorders (MOGAD)
No timeline events available at this time. |
Giulia Fadda, MD | Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon Therapeutics. Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. |